A trial to assess tocilizumab in hepatitis B surface antigen carrier patients with active rheumatoid arthritis who had previously failed treatment with methotrexate or other non-biological disease modifying anti-rheumatics.
Phase of Trial: Phase IV
Latest Information Update: 27 Jul 2015
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 27 Jul 2015 New trial record
- 10 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.